Literature DB >> 6172928

Gluten-free diet for dermatitis herpetiformis: the long-term effect on cutaneous, immunological and jejunal manifestations.

T Frödin, R Gotthard, J Hed, L Molin, K Norrby, A Walan.   

Abstract

In 32 patients with dermatitis herpetiformis (DH) we studied the effect of gluten-free (22 patients) and gluten-reduced (10 patients) diet for periods ranging between 15 and 43 months. Variables such as cutaneous manifestations, dependence on dapsone, IgA deposits in the skin, small-bowel function, and jejunal mucosal morphology were studied. 59% of the patients on gluten-free diet could stop dapsone medication and remain symptom-free, compared with 10% on gluten-reduced diet. The time needed to achieve this therapeutic response varied from 5 to 31 months. IgA decreased in the skin to a degree which roughly paralleled the morphological normalization of the jejunal mucosa. In no patient, however, did the IgA completely disappear. It is suggested that IgA is not the main factor inducing DH symptoms, but rather a secondary phenomenon. Repeated jejunal biopsies revealed normalization of the mucosal histology in 52% of the patients on gluten-free diet, compared with none in the gluten-reduced diet group.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6172928

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

1.  Sequential studies of gliadin antibodies in patients with dermatitis herpetiformis.

Authors:  M Kieffer; R S Barnetson; J N Blackwell
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

2.  Dermatitis herpetiformis: diagnosis, diet and demography.

Authors:  D J Gawkrodger; J N Blackwell; H M Gilmour; E A Rifkind; R C Heading; R S Barnetson
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

3.  Dermatitis herpetiformis: relation between circulating immune complexes, small-intestinal mucosal status, and immunohistopathological findings.

Authors:  E Szabó; S Husz; T Várkonyi; Z F Kiss
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

4.  Dermatitis herpetiformis: 'pH optimum' for the release of potentially antigen-binding IgA fragments from papillary dermis of uninvolved skin by peptic digestion.

Authors:  T Egelrud; O Bäck
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

5.  Cellobiose/mannitol sugar absorption test in patients with dermatitis herpetiformis: a preliminary report.

Authors:  J G Bridges; T J Robinson; K W Scott; H N Pearson
Journal:  Ulster Med J       Date:  1988-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.